Nanoparticles and colloids as contributing factors in neurodegenerative disease

International Journal of Environmental Research and Public Health

Volumn 8, Issue 6, 2011, Pages 2200-2211

  Bondy, Stephen C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colloids; Immune system; Nanoparticles; Neurodegenerative disease; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN; COPPER; IRON; NANOPARTICLE; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSITION ELEMENT; XENOBIOTIC AGENT; ZINC;

AGING; ALZHEIMER DISEASE; BRAIN LEVEL; CLINICAL FEATURE; COLLOID; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MICELLE; NANOANALYSIS; NERVOUS TISSUE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN AGGREGATION; PROTEIN FUNCTION; REVIEW;

EID: 79959850221     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8062200     Document Type: Review

References (73)

1. Sharman, E.H.; Bondy, S.C.; Sharman, K.Z.; Lahiri, D.; Cotman, C.W.; Perreau, V.M. Effects of melatonin and age on gene expression in mouse CNS using microarray analysis. Neurochem. Int. 2007, 50, 336-344.
2. Sloane, J.A.; Hollander, W.; Moss, M.B.; Rosene, D.L.; Abraham, C.R. Increased microglial activation and protein nitration in white matter of the aging monkey. Neurobiol. Aging 1999, 20, 395-405.
3. Streit, W.J.; Miller, K.R.; Lopes, K.O.; Njie, E. Microglial degeneration in the aging brain-bad news for neurons? Front. Biosci. 2008, 13, 3423-3438.
4. Streit, W.J. Microglial senescence: Does the brain's immune system have an expiration date? Trends Neurosci. 2006, 29, 506-510.
5. Frank, M.G.; Barrientos, R.M.; Watkins, L.R.; Maier, S.F. Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo. J. Neuroimmunol. 2010, 226, 181-184.
6. Gorelick, P.B. Role of inflammation in cognitive impairment: Results of observational epidemiological studies and clinical trials. Ann. N. Y. Acad. Sci. 2010, 1207, 155-162.
7. Qian, L.; Flood, P.M.; Hong, J.S. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural Transm. 2010, 117, 971-979.
8. Hsiao, H.Y.; Chern, Y. Targeting glial cells to elucidate the pathogenesis of Huntington's disease. Mol. Neurobiol. 2010, 4, 248-255.
9. Baker, C.A.; Manuelidis, L. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Nat. Acad. Sci. USA 2003, 100, 675-679.
10. Riemer, C.; Gültner, S.; Heise, I.; Holtkamp, N.; Baier, M. Neuro inflammation in prion diseases: Concepts and targets for therapeutic intervention. CNS Neurol. Disord. Drug Target. 2009, 8, 329-341.
11. Shapiro, L.A.; Bialowas-McGoey, L.A.; Whitaker-Azmitia, P.M. Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer'S Disease: Studies in an S100B Overexpressing Mouse Model. Cardiovasc. Psychiat. Neurol. 2010, 2010, Article ID 153657.
12. Salminen, A.; Kauppinen, A.; Suuronen, T.; Kaarniranta, K.; Ojala, J. ER stress in Alzheimer's disease: A novel neuronal trigger for inflammation and Alzheimer's pathology. J. Neuroinflammation 2009, 6, 41.
13. Golde, T.E.; Miller, V.M. Proteinopathy-induced neuronal senescence: A hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res. Ther. 2009, 1, 5.
14. Wilhelmus, M.M.; de Waal, R.M.W.; Verbeek, M.M. Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer's disease. Mol. Neurobiol. 2007, 35, 203-216.
15. van Noort, J.M. Stress proteins in CNS inflammation. J. Pathol. 2008, 214, 267-275.
16. Linnartz, B.; Wang, Y.; Neumann, H. Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation. Int. J. Alzheimers Dis. 2010, 2010, Article ID 587463.
17. Lehnardt, S. Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 5, 253-263.
18. Mandrekar-Colucci, S.; Landreth, G.E. Microglia and inflammation in Alzheimer's disease. CNS Neurol. Disord. Drug Target. 2010, 9, 156-167.
19. Hauss-Wegrzyniak, B.; Lynch, M.A.; Vraniak, P.D.; Wenk, G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 2002, 176, 336-341.
20. Qin, L.; Wu, X.; Block, M.L.; Liu, Y.; Breese, G.R.; Hong, J.S.; Knapp, D.J.; Crews, F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55, 453-462.
21. Vaden, T.D.; Gowers, S.A.; Snoek, L.C. Observation of beta-sheet aggregation in a gas-phase tau-peptide dimer. J. Am. Chem. Soc. 2009, 131, 2472-2474.
22. Ahmed, M.; Davis, J.; Aucoin, D.; Sato, T.; Ahuja, S.; Aimoto, S.; Elliott, J.I.; van Nostrand, W.E.; Smith, S.O. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 2010, 17, 561-567.
23. Ji, H.F.; Zhang, H.Y. Beta-sheet constitution of prion proteins. Trends Biochem. Sci. 2010, 35, 129-134.
24. Heise, H.; Celej, M.S.; Becker, S.; Riedel, D.; Pelah, A.; Kumar, A.; Jovin, T.M.; Baldus, M. Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein. J. Mol. Biol. 2008, 380, 444-450.
25. Nekooki-Machida, Y.; Kurosawa, M.; Nukina, N.; Ito, K.; Oda, T.; Tanaka, M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Nat. Acad. Sci. USA 2009, 106, 9679-9684.
26. Veerhuis, R.; Boshuizen, R.S.; Morbin, M.; Mazzoleni, G.; Hoozemans, J.J.; Langedijk, J.P.; Tagliavini, F.; Langeveld, J.P.; Eikelenboom, P. Activation of human microglia by fibrillar prion protein-related peptides is enhanced by amyloid-associated factors SAP and C1q. Neurobiol. Dis. 2005, 19, 273-282.
27. Darnell, G.; Orgel, J.P.; Pahl, R.; Meredith, S.C. Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure. J. Mol. Biol. 2007, 374, 688-704.
28. Town, T.; Nikolic, V.; Tan, J. The microglial "activation" continuum: From innate to adaptive responses. J. Neuroinflammation 2005, 2, 24.
29. Bodner, R.A.; Outeiro, T.F.; Altmann, S.; Maxwell, M.M.; Cho, S.H.; Hyman, B.T.; McLean, P.J.; Young, A.B.; Housman, D.E.; Kazantsev, A.G. Pharmacological promotion of inclusion formation: A therapeutic approach for Huntington's and Parkinson's diseases. Proc. Nat. Acad. Sci. USA 2006, 103, 4246-4251.
30. Zotova, E.; Holmes, C; Johnston, D.; Neal, J.W.; Nicoll, J.A.; Boche, D. Microglial alterations in human Alzheimer's disease following Ab42 immunisation. Neuropathol. Appl. Neurobiol. 2010, doi: 10.1111/j.1365-2990.2010.01156.x. [Epub ahead of print].
31. Sugama, S.; Takenouchi, T.; Cho, B.P.; Joh, T.H.; Hashimoto, M.; Kitani, H. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm. Allergy Drug Targets 2009, 4, 277-284.
32. Dheen, S.T.; Kaur, C; Ling, E.A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 2007, 14, 1189-1197.
33. Eikelenboom, P.; Bate, C, van Gool, W.A.; Hoozemans, J.J.; Rozemuller, J.M.; Veerhuis, R.; Williams, A. Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002, 40, 232-239.
34. Veerhuis, R.; Boshuizen, R.S.; Familian, A. Amyloid associated proteins in Alzheimer's and prion disease. Curr. Drug Targets CNS Neurol. Disord. 2005, 4, 235-248.
35. Brown, D.R.; Sassoon, J. Copper-dependent functions for the prion protein. Mol. Biotechnol. 2002, 2, 165-178.
36. Wong, B.S.; Liu, T.; Li, R.; Pan, T.; Petersen, R.B.; Smith, M.A.; Gambetti, P.; Perry, G; Manson, J.C.; Brown, D.R.; Sy, M.S. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 2001, 76, 565-572.
37. Peters, A.; Veronesi B.; Calderón-Garcidueñas, L.; Gehr, P.; Chen, L.C.; Geiser, M.; Reed, W.; Rothen-Rutishauser, B.; Schürch, S.; Schulz, H. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Par. Fibre Toxicol. 2006, 8, 3-13.
38. Antonini, J.M.; Sriram, K.; Benkovic, S.A.; Roberts, J.R.; Stone, S.; Chen, B.T.; Schwegler-Berry, D.; Jefferson, A.M.; Billig, B.K.; Felton, C.M. et al. Mild steel welding fume causes manganese accumulation and subtle neuroinflammatory changes but not overt neuronal damage in discrete brain regions of rats after short-term inhalation exposure. Neurotoxicology 2009, 30, 915-925.
39. Oberdörster, G.; Elder, A.; Rinderknecht, A. Nanoparticles and the brain: Cause for concern? Trends Neurosci. 2009, 32, 506-516.
40. van Berlo, D.; Albrecht, C.; Knaapen, A.M.; Cassee, F.R.; Gerlofs-Nijland, M.E.; Kooter, I.M.; Palomero-Gallagher, N.; Bidmon, H.J.; van Schooten, F.J.; Krutmann, J. et al. Comparative evaluation of the effects of short-term inhalation exposure to diesel engine exhaust on rat lung and brain. Arch. Toxicol. 2010, 84, 553-562.
41. Campbell, A.; Oldham, M.; Becaria, A.; Bondy, S.C.; Meacher, D.; Sioutas, C.; Misra, C.; Mendez, L.B.; Kleinman, M. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 2005, 26, 133-140.
42. Kleinman, M.T.; Araujo, J.A.; Nel, A.; Sioutas, C.; Campbell, A.; Cong, P.Q.; Li, H.; Bondy, S.C. Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol. Lett. 2008, 178, 127-130.
43. Wang, J.; Liu, Y.; Jiao, F.; Lao, F.; Li, W.; Gu, Y.; Li, Y.; Ge, C.; Zhou, G.; Li, B.; Zhao, Y.; Chai, Z.; Chen, C. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles. Toxicology 2008, 254, 82-90.
44. Shin, J.A.; Lee, E.J.; Seo, S.M.; Kim, H.S.; Kang, J.L.; Park, E.M. Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse. Neuroscience 2010, 165, 445-454.
45. Win-Shwe, T.T.; Mitsushima, D.; Yamamoto, S.; Fukushima, A.; Funabashi, T.; Kobayashi, T.; Fujimaki, H. Changes in neurotransmitter levels and proinflammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol. Appl. Pharmacol. 2008, 226, 192-198.
46. Trickler, W.J.; Lantz, S.M.; Murdock, R.C.; Schrand, A.M.; Robinson, B.L.; Newport, G.D.; Schlager, J.J.; Oldenburg, S.J.; Paule, M.G.; Slikker, W., Jr. et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol. Sci. 2010, 118, 160-170.
47. Gramowski, A.; Flossdorf, J.; Bhattacharya, K.; Jonas, L.; Lantow, M.; Rahman, Q.; Schiffmann, D.; Weiss, D.G.; Dopp, E. Nanoparticles induce changes of the electrical activity of neuronal networks on microelectrode array neurochips. Environ. Health Perspect. 2010, 118, 1363-1369.
48. Wang, B.; Feng, W.Y.; Wang, M.; Shi, J.W.; Zhang, F.; Ouyang, H.; Zhao, Y.L.; Chai, Z.F.; Huang, Y.Y.; Xie, Y.N. et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: Micro-distribution, chemical states, and histopathological observation. Biol. Trace Elem. Res. 2007, 118, 233-243.
49. Campbell, A.; Yang, Y.; Tsai-Turton, M.; Bondy, S.C. Pro-inflammatory effects of aluminum in human glioblastoma cells. Brain Res. 2002, 933, 62-65.
50. Campbell, A.; Araujo, J.A.; Li, H.; Sioutas, C.; Kleinman, M. Particulate matter induced enhancement of inflammatory markers in the brains of apolipoprotein E knockout mice. Nanosci. Nanotechnol. 2009, 9, 5099-5104.
51. Bondy, S.C. The neurotoxicity of environmental aluminum is still an issue. Neurotoxicology 2010, 31, 575-581.
52. Campbell, A.; Becaria, A.; Lahiri, D.K.; Sharman, K.; Bondy, S.C. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J. Neurosci. Res. 2004, 75, 565-672.
53. Becaria, A.; Lahiri, D.; Bondy, S.C; Chen, D.; Hamadeh, A.; Li, H.; Taylor, R.; Campbell, A. Aluminum and copper in drinking water enhance inflammatory or oxidative events specifically in the brain. J. Neuroimmunol. 2006, 176, 16-23.
54. Mohr, C; Gemsa, D.; Graebner, C; Hemenway, D.R.; Leslie, K.O.; Absher, P.M.; Davis, G.S. Systemic macrophage stimulation in rats with silicosis: Enhanced release of tumor necrosis factor-alpha from alveolar and peritoneal macrophages. Am. J. Respir. Cell. Mol. Biol. 1991, 5, 395-402.
55. Rajendran, R.; Minqin, R.; Ynsa, M.D.; Casadesus, G; Smith, M.A.; Perry, G; Halliwell, B.; Watt, F. A novel approach to the identification and quantitative elemental analysis of amyloid deposits-insights into the pathology of Alzheimer's disease. Biochem. Biophys. Res. Commun. 2009, 382, 91-95.
56. Bondy, S.C; Kirstein, S. The promotion of iron-induced generation of reactive oxygen species in nerve tissue by aluminum. Mol. Chem. Neuropathol. 1996, 27, 185-194.
57. Bondy, S.C; Guo-Ross, S.X.; Truong, A.T. Promotion of transition metal-induced production of reactive oxygen species formation by β-amyloid. Brain Res. 1998, 799, 91-96.
58. Bondy, S.C; Guo-Ross, S.X.; Pien, J. Mechanisms underlying aluminum-induced potentiation of oxidant properties of transition metals. Neurotoxicology 1998b, 19, 65-72.
59. Yang, E.Y.; Guo-Ross, S.X.; Bondy, S.C. The stabilization of ferrous iron by a toxic β-amyloid fragment and by an aluminum salt. Brain Res. 1999, 799, 91-96.
60. HaMai, D.; Bondy, S.C; Becaria, V.; Campbell, A. The chemistry of transition metals in relation to their potential role in neurodegenerative processes. Curr. Top. Med. Chem. 2001, 1, 541-551.
61. Bondy, S.C; HaMai, D. Oxidative basis of manganese neurotoxicity. Ann. N. Y. Acad. Sci. 2004, 1012, 129-141.
62. Voinov, M.A.; Pagán, J.O.; Morrison, E.; Smirnova, T.I.; Smirnov, A.I. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity J. Am. Chem. Soc. 2011, 133, 35-41.
63. Panduri, V.; Weitzman, S.A.; Chandel, N.S.; Kamp, D.W. Mitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286, L1220-L1227.
64. Smith, D.G.; Cappai, R.; Barnham, K.J. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim. Biophys. Acta 2007, 1768, 1976-1990.
65. Exley, C.J. Aluminium and iron, but neither copper nor zinc, are key to the precipitation of β-sheets of Aβ42 in senile plaque cores in Alzheimer's disease. J. Alzheim. Dis. 2006, 10, 173-177.
66. Santner, A.; Uversky, V.N. Metalloproteomics and metal toxicology of α-synuclein. Metallomics 2010, 2, 378-392.
67. Brewer, G.J. Risks of copper and iron toxicity during aging in humans. Chem. Res. Toxicol. 2010, 23, 319-326.
68. Bolognin, S.; Drago, D.; Messori, L.; Zatta, P. Chelation therapy for neurodegenerative diseases. Med. Res. Rev. 2009, 29, 547-570.
69. Horowitz, M.P.; Greenamyre, J.T. Mitochondrial iron metabolism and its role in neurodegeneration. J. Alzheim. Dis. 2010, 20 (Suppl 2), S551-S568.
70. Yang, G.; Meng, Y.; Li, W.; Yong, Y.; Fan, Z.; Ding, H.; Wei, Y.; Luo, J.; Ke, Z.J. Neuronal MCP-1 Mediates Microglia Recruitment and Neurodegeneration Induced by the Mild Impairment of Oxidative Metabolism. Brain Pathol. 2011, 21, 279-297.
71. Eder, C. Ion channels in monocytes and microglia/brain macrophages: Promising therapeutic targets for neurological diseases. J. Neuroimmunol. 2010, 224, 51-55.
72. Lee, C.; Sedlak, D.L. Enhanced formation of oxidants from bimetallic nickel-iron nanoparticles in the presence of oxygen. Environ. Sci. Technol. 2008, 42, 8528-8533.
73. Jiang, L.; Nagai, H.; Ohara, H.; Hara, S.; Tachibana, M.; Hirano, S.; Shinohara, Y.; Kohyama, N.; Akatsuka, S.; Toyokuni, S. Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci. 2008, 99, 2142-2151.